Evaluation of an intervention to promote walking during the commute to work: a cluster randomised controlled trial.
Active travel
Behavioural intervention
Physical activity
Randomised controlled trial
Walking
Workplace
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
24 Apr 2019
24 Apr 2019
Historique:
received:
14
03
2018
accepted:
09
04
2019
entrez:
25
4
2019
pubmed:
25
4
2019
medline:
14
6
2019
Statut:
epublish
Résumé
Opportunities for working adults to accumulate recommended physical activity levels (at least 150 min of moderate intensity physical activity in bouts of at least 10 min throughout the week) may include the commute to work. Systematic reviews of interventions to increase active transport suggest studies have tended to be of poor quality, relying on self-report and lacking robust statistical analyses. We conducted a multi-centre parallel-arm cluster randomised controlled trial, in workplaces in south-west England and south Wales, to assess the effectiveness of a behavioural intervention to increase walking during the commute. Workplace-based Walk to Work promoters were trained to implement a 10-week intervention incorporating key behavioural change techniques: providing information; encouraging intention formation; identifying barriers and solutions; goal setting; self-monitoring; providing general encouragement; identifying social support; reviewing goals, and; relapse prevention. Physical activity outcomes were objectively measured using accelerometers and GPS receivers at baseline and 12-month follow-up. The primary outcome was daily minutes of moderate to vigorous physical activity (MVPA). Secondary outcomes included overall levels of physical activity and modal shift (from private car to walking). Cost-consequences analysis included employer, employee and health service costs and outcomes. Six hundred fifty-four participants were recruited across 87 workplaces: 10 micro (5-9 employees); 35 small (10-49); 22 medium (50-250); 20 large (250+). The majority of participants lived more than two kilometres from their place of work (89%) and travelled to work by car (65%). At 12-month follow-up, 84 workplaces (41 intervention, 43 control) and 477 employees (73% of those originally recruited) took part in data collection activities. There was no evidence of an intervention effect on MVPA or overall physical activity at 12-month follow-up. The intervention cost on average £181.97 per workplace and £24.19 per participating employee. The intervention, focusing primarily on individual behaviour change, was insufficient to change travel behaviour. Our findings contribute to the argument that attention should be directed towards a whole systems approach, focusing on interactions between the correlates of travel behaviour. ISRCTN15009100 . Prospectively registered. (Date assigned: 10/12/2014).
Sections du résumé
BACKGROUND
BACKGROUND
Opportunities for working adults to accumulate recommended physical activity levels (at least 150 min of moderate intensity physical activity in bouts of at least 10 min throughout the week) may include the commute to work. Systematic reviews of interventions to increase active transport suggest studies have tended to be of poor quality, relying on self-report and lacking robust statistical analyses.
METHODS
METHODS
We conducted a multi-centre parallel-arm cluster randomised controlled trial, in workplaces in south-west England and south Wales, to assess the effectiveness of a behavioural intervention to increase walking during the commute. Workplace-based Walk to Work promoters were trained to implement a 10-week intervention incorporating key behavioural change techniques: providing information; encouraging intention formation; identifying barriers and solutions; goal setting; self-monitoring; providing general encouragement; identifying social support; reviewing goals, and; relapse prevention. Physical activity outcomes were objectively measured using accelerometers and GPS receivers at baseline and 12-month follow-up. The primary outcome was daily minutes of moderate to vigorous physical activity (MVPA). Secondary outcomes included overall levels of physical activity and modal shift (from private car to walking). Cost-consequences analysis included employer, employee and health service costs and outcomes.
RESULTS
RESULTS
Six hundred fifty-four participants were recruited across 87 workplaces: 10 micro (5-9 employees); 35 small (10-49); 22 medium (50-250); 20 large (250+). The majority of participants lived more than two kilometres from their place of work (89%) and travelled to work by car (65%). At 12-month follow-up, 84 workplaces (41 intervention, 43 control) and 477 employees (73% of those originally recruited) took part in data collection activities. There was no evidence of an intervention effect on MVPA or overall physical activity at 12-month follow-up. The intervention cost on average £181.97 per workplace and £24.19 per participating employee.
CONCLUSIONS
CONCLUSIONS
The intervention, focusing primarily on individual behaviour change, was insufficient to change travel behaviour. Our findings contribute to the argument that attention should be directed towards a whole systems approach, focusing on interactions between the correlates of travel behaviour.
TRIAL REGISTRATION
BACKGROUND
ISRCTN15009100 . Prospectively registered. (Date assigned: 10/12/2014).
Identifiants
pubmed: 31014313
doi: 10.1186/s12889-019-6791-4
pii: 10.1186/s12889-019-6791-4
pmc: PMC6480724
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
427Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom
Organisme : Department of Health
ID : PHR/13/117/01
Pays : United Kingdom
Organisme : Public Health Research Programme
ID : 13/117/01
Références
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
BMJ. 2004 Oct 2;329(7469):763
pubmed: 15385407
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003180
pubmed: 15674903
BMJ. 2007 Jun 9;334(7605):1204
pubmed: 17540909
Int J Behav Nutr Phys Act. 2008 Nov 06;5:56
pubmed: 18990237
Med Sci Sports Exerc. 2011 Jul;43(7):1235-43
pubmed: 21131863
Public Health. 2011 Apr;125(4):210-6
pubmed: 21458011
Int J Behav Nutr Phys Act. 2011 Nov 10;8:124
pubmed: 22074293
Obes Facts. 2011;4(6):479-88
pubmed: 22249000
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Br J Gen Pract. 2012 Dec;62(605):664-6
pubmed: 23211256
Prev Med. 2013 Mar;56(3-4):211-7
pubmed: 23375993
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Br J Health Psychol. 2014 Feb;19(1):149-80
pubmed: 23827053
PLoS One. 2013 Jun 19;8(6):e67575
pubmed: 23840743
Health Econ. 2015 Mar;24(3):258-69
pubmed: 24254584
BMJ. 2014 Aug 19;349:g4887
pubmed: 25139861
BMC Public Health. 2015 Feb 18;15:154
pubmed: 25884986
Int J Behav Nutr Phys Act. 2015 Feb 11;12:12
pubmed: 25888840
PLoS One. 2017 Feb 9;12(2):e0171374
pubmed: 28182714
Br J Sports Med. 2018 Jun;52(12):769-775
pubmed: 29858464
J Transp Health. 2018 Jun;9:45-55
pubmed: 29951354
Med Sci Sports Exerc. 1998 May;30(5):777-81
pubmed: 9588623